Exagen Inc expected to post a loss of 20 cents a share - Earnings Preview

Exagen

02/05/2025 15:30

Exagen Inc XGN.OQ XGN.O is expected to show a rise in quarterly revenue when it reports  results on May 5 for the period ending March 31 2025

The Vista California-based  company is expected to report a 0.9% increase in revenue to $14.543 million from $14.42 million a year ago, according to the mean estimate from 6 analysts, based on LSEG data.The company's guidance on March 11 2025, for the period ended March 31, was for revenue of $14.500 million.

​LSEG's mean analyst estimate for Exagen Inc is for a loss of 20 cents per share.

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 5 "strong buy" or "buy," 1 "hold" and no "sell" or "strong sell."

The mean earnings estimate of analysts was unchanged in the last three months. ​

Wall Street's median 12-month price target for Exagen Inc is $7.00​, above​ its last closing price of $6.14. ​​​

Previous quarterly performance (using preferred earnings measure in US dollars). ​

QUARTER ENDING
STARMINESMARTESTIMATE®
LSEG IBES ESTIMATE
ACTUAL
BEAT, MET, MISSED
SURPRISE %
Dec. 31 2024
-0.26
-0.26
-0.20
Beat
23.1
Sep. 30 2024
-0.29
-0.29
-0.28
Beat
3.4
Jun. 30 2024
-0.34
-0.34
-0.16
Beat
53.6​
Mar. 31 2024
-0.36
-0.36
-0.19
Beat
47.5
​​Dec. 31 2023
-0.40
-0.43
-0.31
Beat
28.5
Sep. 30 2023
-0.46
-0.47
-0.31
Beat
34​
Jun. 30 2023
-0.50
-0.49
-0.28
Beat
43.4
Mar. 31 2023
-0.57
-0.56
-0.44
Beat
21.7

This summary was machine generated May 2 at 14:30 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)